New York, NY -- (SBWIRE) -- 10/31/2014 -- Diabetic nephropathy is a disease of kidney glomerulus. Diabetic nephropathy is caused by high blood sugar or diabetes and high blood pressure and results in kidney damage. Balanced glomerular filtration rate decreases in the damage to kidney. Decrease in the filtration rates builds up waste products in the blood and increases the level of protein in urine. Severe kidney damage can lead to kidney failure which required kidney transplantation. Treatment of diabetic nephropathy includes glycemic control and blood pressure control. Rise in incidence of diabetes cases and increasing awareness about the diabetes and its treatment therapies are some of the major factors which are driving the market for diabetic nephropathy. Some of the symptoms of diabetic nephropathy are abnormal sensations to body part, loss of control over bladder, intense pain, erectile dysfunction, dizziness, speech impairment and others. Diabetic nephropathy therapies include drugs therapy, physiotherapy and radio therapy. Drugs therapy includes antispasmodic and antidepressant. Radio therapy includes transcutaneous electric nerve stimulation (TENS). These therapies help to control diabetes diabetic nephropathy that can cause eye damage and heart disease.

Buy Full Report:
http://www.persistencemarketresearch.com/market-research/diabetic-nephropathy-market.asp

North America, followed by Europe, has the largest market for diabetic nephropathy due to advanced healthcare solutions, rise in incidence of kidney diseases, growing concern about diabetes and developed healthcare infrastructure in this region. Asia is expected to experience high growth rate in the companion diagnostics market in next few years due to rise in incidence of diabetes cases, growing need for better chronic kidney disease treatments and therapies, increasing awareness about the diabetes diagnosis, rise in healthcare expenditure and developing healthcare infrastructure in the region.

Increasing incidence of diabetes cases, technological advancement, drug innovations for the treatment of diabetic nephropathy, government initiatives, rise in aging population and advance healthcare services are expected to drive the market for diabetic nephropathy. In addition, rise in awareness about kidney diseases and their therapies available in the market and increasing healthcare expenditure are driving the global market for diabetic nephropathy. However, rise in number of patent expirations, asymptomatic nature of the disease and rise in use of generic drugs are some of the major factors restraining the growth for global diabetic nephropathy market.

Growing demographics and economies in the developing countries such as India and China is expected to lead the growth in diabetic nephropathy market in Asia. In addition, rise in awareness about diabetes and its treatment therapies available in the market, innovation in drug development and technological advancement are expected to drive the market for diabetic nephropathy. Increasing number of mergers and acquisitions, rise in number of collaborations and partnerships. New product launches and growing awareness about the availability of diabetic nephropathy drugs are some of the latest trends that have been observed in global diabetic nephropathy market. Some of the major companies operating in the global diabetic nephropathy market are Novartis AG, Merck & Co. Inc., Sanofi S.A., Mitsubishi Tanabe Pharma Corp., AbbVie Inc., Bayer AG and Questcor Pharmaceuticals Inc. In addition, some other companies operating in global diabetic nephropathy market are Ampio Pharmaceuticals Inc., Glaxo Smith Kline, Eli Lilly and Co., NephroGenex Inc., Pfizer Inc. and ChemoCentryx Inc.

Request Full TOC:
http://www.persistencemarketresearch.com/toc/3594

About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.